Cartesian Therapeutics Inc (RNAC)

15.76 -8.50 (-35.04%) USD  |  NASDAQ  |  Jul 02, 16:00
16.25 +0.48 (+3.08%) After-Hours: 20:00
More

Cartesian Therapeutics Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for RNAC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2023. Upgrade now.
Date Value
July 02, 2024 --
June 04, 2024 --
May 30, 2024 --
May 24, 2024 --
May 09, 2024 --
May 08, 2024 --
Date Value
April 23, 2024 --
April 09, 2024 --
March 11, 2024 --
March 04, 2024 --
February 07, 2024 --
December 31, 2023 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

--
Minimum
Mar 11 2024
Upgrade
Maximum
Feb 07 2024
Upgrade
Average
Upgrade
Median

Revenue Estimates for Current Fiscal Year Benchmarks

Marinus Pharmaceuticals Inc Upgrade
Adial Pharmaceuticals Inc Upgrade
Poseida Therapeutics Inc Upgrade
Viracta Therapeutics Inc Upgrade
Biomea Fusion Inc Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade